Cite
MLA Citation
C E McInerney et al.. “BTC1.04 Genomic profiling of IDH-wildtype and IDH-mutant initial and matched recurrent glioblastomas reveals clinically actionable mutations (e.g. BRCA1/2) and resistance signatures.” Neuro-oncology, vol. 20, n.d., pp. iii215–iii216. http://access.bl.uk/ark:/81055/vdc_100095508401.0x000018